[ RadSafe ] French Nuclear Agency Finds Higher Rates of Child Leukemia

[Perle, Sandy]

IRSN is a well-respected organization and I know many in their dosimetry
programs. In my opinion every study should be looked at the factual
content of what the study covered, the data that was used and then
determine if the data was used appropriately or not. Every study can't
simply be dismissed because it differs from what the audience wants to
see, or accepted because it goes hand in hand with what the audience wants
to see.

One only need look at chemicals, prescription medications that once were
thought to be safe, used for decades and now there is evidence that these
are actually harmful to humans. We should not be dismissive without actual
review of what is being stated.

Regards,

Sandy

-----------------------------------
Sander C. Perle 
President
Mirion Technologies
Dosimetry Services Division
2652 McGaw Avenue
Irvine, CA 92614
 
+1 (949) 296-2306 (Office)
+1 (949) 296-1130 (Fax)
 
Mirion Technologies: http://www.mirion.com/





On 1/12/12 1:42 AM, "Roger Helbig" <rwhelbig at gmail.com> wrote:

>This has just come out - I wonder how much the past flawed Busby work
>influenced Laurier
>
>French nuclear plants double child leukemia ­ study TVNZ January 12,
>2012 Source: Reuters The incidence of leukaemia is twice as high in
>children living close to French nuclear power plants as in those
>living elsewhere in the country, a study by French health and nuclear
>safety experts has found.
>
>But the study, to be published soon in the International Journal of
>Cancer, fell short of establishing a causal link between the higher
>incidence of leukaemia, a type of blood cancer, and living near
>nuclear power plants..
>
>Š The study, conducted by the French health
>research body INSERM, found that between 2002 and 2007, 14 children
>under the age of 15 living in a 5km radius of France¹s 19 nuclear
>power plants had been diagnosed with leukaemia.
>
>This is double the rate of the rest of the country, where a total of
>2,753 cases were diagnosed in the same period.
>
>³This is a result which has been checked thoroughly and which is
>statistically significant,² said Dominique Laurier, head of the
>epidemiology research laboratory at France¹s nuclear safety research
>body (IRSN)ŠŠ
>we are working on numbers which are very small and results have to be
>analysed with a lot of care,² said Laurier, one of the authors of the
>study.
>
>Laurier said the findings indicated no difference in risk between
>sites located by the sea or by rivers, nor according to the power
>capacity of the plant. The IRSN said it recommended a more thorough
>study of the causes of the leukaemia cases found near nuclear power
>stations and hoped to set up international research collaboration.
>
>³It¹s a rare disease and working on a bigger scale would allow more
>stable results,² said LaurierŠŠ
>Studies have been conducted around the world into possible links
>between the risk of childhood blood cancers and living near nuclear
>plants.
>
>A study on Germany, published in 2007, did find a significantly
>increased risk, but the COMARE team said these findings were probably
>influenced by an unexplained leukaemia cluster near a nuclear plant in
>Krummel, north Germany,Š.
>http://tvnz.co.nz/world-news/french-nuclear-plants-double-child-leukemia-s
>tudy-4684348
>_______________________________________________
>You are currently subscribed to the RadSafe mailing list
>
>Before posting a message to RadSafe be sure to have read and understood
>the RadSafe rules. These can be found at:
>http://health.phys.iit.edu/radsaferules.html
>
>For information on how to subscribe or unsubscribe and other settings
>visit: http://health.phys.iit.edu